Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.

Coronavirus close up © Shutterstock

Regretfully, we are announcing the closure of the Kennedy and Botnar Institutes effective from noon on Wednesday 25 March. The Kadoorie Centre based at the John Radcliffe Hospital will remain open for staff working in clinical roles in the NHS and for essential follow-up of patients already recruited into clinical studies.

Many of our staff and postgraduate students will be continuing their day-to-day work from home, while others may take on or extend a clinical role to support the NHS in the fight against COVID-19. Some of our research teams are working towards solutions to contain the spread of coronavirus and we will share updates on this as we have them.

All new clinical research will be put on hold and recruitment of new participants to our clinical studies in Oxford will be paused.

For students, teaching and learning in Trinity term will be moved to an online format where possible, and there will be no conventional written paper exams. Detailed planning continues but our aim throughout is to ensure students can continue, or complete, their academic careers at Oxford. Most of our scheduled workshops/modules for postgraduate research students have been postponed and students are being advised to keep in touch with their supervisors.

Professor Andrew Carr, Head of Department said: "Researchers at NDORMS and across Oxford are at the forefront of global efforts to understand this coronavirus (COVID-19) and protect our communities.

I would like to thank all our teams at NDORMS who are supporting these efforts and the very responsible and collegiate way in which you have responded to this unprecedented situation. It is very stressful and disruptive for everyone particularly those with extra risk factors. In addition, many members of the department have family members and loved ones who are at high risk and many live in other countries where restrictions to travel make visits impossible."

The University of Oxford COVID-19 research hub features regular updates about the latest research publications and longer-form pieces covering the many ways Oxford is approaching this pandemic: www.ox.ac.uk/coronavirus-research.

Funding for Oxford's COVID-19 research requires unprecedented speed, scope and ambition and anyone wishing to fund the university's efforts can donate here: http://www.ox.ac.uk/coronavirus-research/support

For more information please contact communications@ndorms.ox.ac.uk in the first instance, and we can direct your enquiry to the appropriate team.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.